Federal contract award

75N95024F00001

CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CTN PORTFOLIO SUPPORT (NON-HEAL). 8/15/24 - 8/14/25

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIDA
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicle75N95024D00037
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$4.1M
Current contract value$4.1M
Potential contract value / ceiling$4.1M
Start dateAug 15, 2024
Current end dateAug 14, 2025
Potential end dateAug 14, 2025
Latest award activityAug 30, 2024
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 30, 2024P00001$463.2KCLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CTN PORTFOLIO SUPPORT (NON-HEAL). 8/15/24 - 8/14/25
Aug 13, 20240$3.7MCLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CTN PORTFOLIO SUPPORT (NON-HEAL). 8/15/24 - 8/14/25

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Polina KlimenkovaContactpolina.klimenkova@nih.gov
3018276848
SourceDec 27, 2023
Josh LazarusContactjosh.lazarus@nih.gov
3018276923
SourceDec 27, 2023
Polina KlimenkovaContactpolina.klimenkova@nih.gov
3018276848
SourceDec 8, 2023
Josh LazarusContactjosh.lazarus@nih.gov
3018276923
SourceDec 8, 2023

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.